Order Article Reprints

Guliyev M, Güren AK, Özge E, Çolak R, Majidova N, Alkan Şen G, Safarov S, Günaltılı M, Fidan MC, Gültürk İ, et al. The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors. Cancers. 2025; 17(4):693. https://doi.org/10.3390/cancers17040693

Guliyev, Murad, Ali Kaan Güren, Emre Özge, Rumeysa Çolak, Nargiz Majidova, Gülin Alkan Şen, Shamkhal Safarov, Murat Günaltılı, Mehmet Cem Fidan, İlkay Gültürk, and et al. 2025. "The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors" Cancers 17, no. 4: 693. https://doi.org/10.3390/cancers17040693

Guliyev, M., Güren, A. K., Özge, E., Çolak, R., Majidova, N., Alkan Şen, G., Safarov, S., Günaltılı, M., Fidan, M. C., Gültürk, İ., Yılmaz, M., Bayoğlu, İ. V., Demirci, N. S., & Alan, Ö. (2025). The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors. Cancers, 17(4), 693. https://doi.org/10.3390/cancers17040693